• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

The Evolution of Prostacyclins in Pulmonary Arterial Hypertension: From Classical Treatment to Modern Management

Publication
Article
Supplements and Featured PublicationsThe Evolution of Prostacyclins in Pulmonary Arterial Hypertension: From Classical Treatment to Moder
Volume 22
Issue 1 Suppl

Publishing Staff

Senior Vice President of Operations and Clinical Affairs

Jeff D. Prescott, PharmD, RPh

Senior Clinical Projects Manager

Ida Delmendo

Clinical Projects Manager

Cindy Spielvogel

Project Manager

Jessica Toye

Proofreaders

Griselda DemasseyMaggie Shaw

Associate Editor

Jeanne Linke

Clinical Editor

Michael R. Page, PharmD, RPh

Designer

Julianne Costello

Associate Publisher

Justin T. Gallagher

Director of Sales

Sara Belanger

National Account Managers

Gabrielle ConsolaMichael Costella

Corporate

Chairman and CEO

Mike Hennessy, Sr

Vice Chairman

Jack Lepping

President

Mike Hennessy, Jr

Chief Operating Officer/CFO

Neil Glasser, CPA/CFE

President, Managed Markets, Pharmacy,

and Rare Disease

Brian Haug

Executive Vice President

and General Manager

John Maglione

Human Resources Director

Shari Lundenberg

Chief Creative Officer

Jeff Brown

PARTICIPATING FACULTYFaculty

Charles D. Burger, MD, FCCP

Medical Director

Comprehensive Pulmonary Hypertension Center

Mayo Clinic Florida

Professor of Medicine

Mayo Clinic College of Medicine

Jacksonville, Florida

Lesley D’Albini, PharmD, BCPS

Senior Clinical Practice Manager

Accredo Health Group Inc, an Express Scripts Company

Memphis, Tennessee

Janis A. Pruett, EdD, RN, MSN, CDE, FNP-BC

Associate Director

Medical Managed Markets and Health Economics and Outcomes

Research

Medical Affairs Department

Actelion Pharmaceuticals US, Inc

South San Francisco, California

Susan Raspa, RN, BSN

Associate Director

Medical Affairs

Actelion Pharmaceuticals US, Inc

South San Francisco, California

Faculty Disclosures

These faculty report relationships with the following organizations:

Charles D. Burger, MD, FCCP

Consultant/advisory board member:

Actelion Pharmaceuticals US, Inc; Gilead Sciences, Inc

Grants:

Actelion Pharmaceuticals US, Inc; Gilead Sciences, Inc;

United Therapeutics Corp

Lesley D’Albini, PharmD, BCPS

Employment and stock ownership:

Accredo Specialty Pharmacy

Janis A. Pruett, EdD, RN, MSN, CDE, FNP-BC

Employment and stock ownership:

Actelion Pharmaceuticals US, Inc

Susan Raspa, RN, BSN

Employment and stock ownership:

Actelion Pharmaceuticals US, Inc

© 2024 MJH Life Sciences
AJMC®
All rights reserved.